MRSH 10-K Analysis: Cash Flow Grew 10x Faster Than Profits

Marsh, the world's largest insurance broker, generated $5 billion in free cash flow in FY2025 — 25% more than the prior year — yet earnings per share grew just 3.1%. That 10:1 divergence between cash and GAAP earnings is the most important number in the company's 10-K filing, and it is buried under a headline narrative about the largest acquisition in company history.

The surface-level story is straightforward enough. Marsh completed its $7.75 billion acquisition of McGriff Insurance Services in January 2025, driving total revenue up 10.3% to $27.0 billion. Management emphasized the growth, the integration progress, and the launch of a new $400 million savings program called Thrive. Analysts focused on the expected year-one acquisition drag. Nobody questioned the math.

But the 10-K tells a more complicated story. Expenses grew 11% against that 10% revenue increase — negative operating leverage that compressed GAAP operating margin by 72 basis points. The R&I segment, which houses the McGriff business, saw its operating margin fall 160 basis points. And the company's claim of "18th consecutive year of margin expansion" is unsupported by any calculation method applied to the filing data. Every margin measure — GAAP, adjusted, and even ex-all-charges — contracted in FY2025. The question for investors is not whether McGriff created a temporary drag. It is whether the $5 billion cash flow engine underneath the GAAP noise is as durable as the capital return policy assumes.

The McGriff Margin Tax: What $7.75 Billion Actually Bought

The McGriff acquisition's headline contribution — 6% of Marsh's 10% revenue growth — obscures the cost of that revenue. The R&I segment, which absorbed McGriff, generated $17.27 billion in revenue and $4.64 billion in operating income in FY2025, producing a 26.8% operating margin. A year earlier, R&I operated at 28.4%. That 160-basis-point decline is not just an acquisition integration story. It is a revenue quality story.

The incremental margin calculation reveals the gap. R&I added $1.87 billion in new revenue year-over-year but only $264 million in new operating income — an incremental operating margin of just 14.1%. That is half the segment's 28.4% base margin. Every dollar of new R&I revenue generated only 14 cents of operating profit, compared to 28 cents from the existing business.

Compare that to Consulting, where the incremental margin was 18.8% — nearly matching its 19.4% base. The margin problem is not company-wide. It is isolated entirely to R&I, where McGriff revenue is arriving at dramatically lower profitability than the organic business.

The interest expense burden makes the acquisition's year-one cost to shareholders concrete. The 10-K attributes the entire $260 million increase in interest expense — from $700 million to $960 million — directly to McGriff financing.

"Interest expense was $960 million in 2025, compared to $700 million in 2024. Interest expense increased $260 million in 2025 due to debt raised to fund the McGriff acquisition."

After tax, that $260 million in incremental interest expense cost shareholders approximately $0.40 per share in EPS — roughly half of the entire EPS growth shortfall between revenue (+10%) and earnings (+3%). Add $211 million in integration costs and $549 million in intangible amortization, and the full picture emerges: McGriff added substantial revenue but sent nearly $1 billion in acquisition-related charges through the income statement.

The decomposition reveals why the 10:1 divergence between FCF and EPS is not accidental. The intangible amortization alone creates a $1.11 per share gap between GAAP earnings and cash — it flows through the income statement but never touches the cash flow statement. This is a permanent feature of any acquisition-heavy company, and for Marsh it amounts to a 200-basis-point structural GAAP margin drag with zero economic cost.

"Consolidated operating income increased $406 million, or 7% to $6.2 billion in 2025, compared to $5.8 billion in 2024, reflecting a 10% increase in revenue and an 11% increase in expenses."

Even stripping out all one-time charges — $211 million in integration costs, $134 million in R&I restructuring, and $222 million in company-wide restructuring — the ex-charges margin still contracted 48 basis points. This means the underlying business, not just the acquisition noise, experienced margin pressure. Marsh's Risk & Insurance segment generated 14.1% incremental operating margin on $1.87 billion of new revenue in FY2025 — half the 28.4% base margin — revealing that the McGriff acquisition added revenue at dramatically lower profitability than the existing business.

The Cash Earnings Machine Beneath the GAAP Noise

If the income statement tells the story of an acquisition-burdened company, the cash flow statement tells the story of a machine. Marsh generated $5.29 billion in operating cash flow in FY2025, up 23% from $4.30 billion. After $291 million in capex — just 1.1% of revenue — free cash flow was $5.0 billion.

"The Company provided $5.3 billion of cash from operations in 2025 compared to $4.3 billion in 2024."

The OCF/NI ratio of 1.27x means Marsh converted every dollar of reported net income into $1.27 of cash. This is not a one-time anomaly. The structural driver is the $549 million in intangible amortization — a non-cash charge that reduces reported earnings by 200 basis points without consuming a single dollar. Favorable working capital timing and deferred tax benefits added to the cash advantage, though these may partially reverse in FY2026.

What makes this significant is relative positioning. Among Marsh's five financial services peers, the 1.27x cash conversion ratio stands alone.

BlackRock — the closest comparable asset manager — converts at just 0.71x. BLK's $28 billion acquisition spree (GIP, HPS, Preqin) consumed working capital and generated integration outlays that drag cash flow well below net income. Schwab converts at approximately 1.11x, respectable but still 16 points below Marsh. The banks — Citigroup and Royal Bank of Canada — operate on fundamentally different cash flow frameworks, but even excluding them, Marsh leads all fee-based peers.

The cash advantage reframes the valuation question. At 21.9x trailing P/E, Marsh looks expensive relative to Citigroup (16.4x) or Royal Bank (11.1x). But those are balance-sheet-intensive banks trading at bank-like multiples. On a cash earnings basis — $188 divided by $10.12 in FCF per share — Marsh trades at 18.6x, closer to a reasonably priced compounder. The 5.5% FCF yield offers a more direct comparison to bond yields than the 4.6% earnings yield.

The market narrative that Marsh suffered "weak earnings growth" in FY2025 misses the point. GAAP earnings grew 2.5% because $982 million in non-core charges — restructuring, integration, and intangible amortization — flowed through the income statement. Cash earnings grew more than ten times faster because those same charges either don't consume cash (amortization) or are declining (integration costs). Marsh's free cash flow surged 25.5% to $5.0 billion in FY2025, growing ten times faster than the 2.5% increase in net income, because $549 million in non-cash intangible amortization and favorable working capital shifts channeled profitability into cash rather than reported earnings.

Management's claim of "18th consecutive year of margin expansion" adds a credibility question. The 10-K's own numbers show GAAP operating margin fell from 23.78% to 23.06% — a 72-basis-point decline. Adjusted margin fell 67 basis points. Even stripping ALL restructuring, integration, and restructuring-related charges, margin still contracted 48 basis points. The claim, attributed to earnings materials, is unsupported by any calculation method applied to the filing data. Investors relying on management's qualitative framing are looking at a different picture than what the 10-K quantifies.

Marsh's negative tangible book value of -$29.1 billion — driven by $24.3 billion in goodwill from decades of acquisitions — makes traditional return-on-capital metrics meaningless. ROE and ROIC cannot be calculated on near-zero or negative equity. This is why the cash flow lens is not optional but necessary: FCF yield and OCF/NI are the only reliable valuation anchors for a company whose balance sheet is structurally defined by acquisition history rather than tangible assets. Mercer's management of $692 billion in assets worldwide — making it a top-25 global asset manager — adds a capital-markets-driven revenue dimension that reinforces the franchise's durability, even as 51% of total revenue comes from international operations with significant foreign exchange exposure.

The Capital Return Paradox: Confidence or Recklessness at $19.6 Billion in Debt

Marsh returned $3.71 billion to shareholders in FY2025 — $1.70 billion in dividends and $2.01 billion in share buybacks. That is 89.2% of net income, returned to shareholders while the company carries $19.6 billion in total debt. In November 2025, the Board authorized a new $6 billion buyback program, with $5.7 billion remaining.

"In November 2025, the Board of Directors authorized an increase in the Company's share repurchase program, which supersedes any prior authorization, allowing management to buy back up to $6 billion of the Company's common stock."

The acceleration is significant. Buybacks more than doubled from $0.90 billion to $2.01 billion — a 124% increase. Total capital returned rose 54% year-over-year. This is management broadcasting its conviction that the $5 billion free cash flow stream is permanent enough to simultaneously service $19.6 billion in debt and return nearly all earnings to shareholders.

But the fifth row of that table is the complication. Interest coverage fell from 8.3x to 6.5x in a single year, entirely due to the $260 million increase in interest expense from McGriff acquisition financing. At 6.5x, coverage is comfortable — investment-grade territory. But the trajectory matters: the company is simultaneously increasing capital returns and watching its debt service buffer shrink.

The filing's own risk factors acknowledge the tension directly.

"The level of debt outstanding could adversely affect our financial flexibility by reducing our cash flows and our ability to use cash from operations for other purposes, including working capital, dividends to shareholders, share repurchases, acquisitions, capital expenditures and general corporate purposes."

Near-term maturities add a refinancing headwind. Bonds at 1.349% and 3.750% come due in 2026 and will be refinanced at current market rates around 5%, adding an estimated $30-50 million in annual interest expense. The direction is clear: interest costs are rising, and they will continue to rise until the low-coupon acquisition-era debt rolls over.

CEO John Doyle sold 16,655 shares — 12.48% of his personal holdings — at $183.30, and BofA downgraded the stock to Underperform with a $181 target citing premium rate softening. Neither of these signals is definitive. Insider selling may reflect personal diversification. Analyst downgrades reflect one firm's view. But combined with the interest coverage trajectory, they provide a context for the capital return decision: management is returning 89% of net income because it believes the cash flow engine is effectively permanent, but external signals suggest the margin of safety is narrower than the buyback pace implies.

The capital return paradox has a clear resolution condition. It depends on organic growth sustainability. At 4% underlying growth and $5 billion in annual FCF, the math works: debt can be serviced, dividends can grow, and buybacks can absorb share dilution. But a recession-driven 25% earnings decline would push interest coverage to approximately 5x and force a choice between maintaining the buyback pace and maintaining balance sheet health. Marsh returned $3.7 billion to shareholders in FY2025 — 89% of net income — while carrying $19.6 billion in debt and facing interest coverage that fell from 8.3x to 6.5x, a capital allocation bet that works only if the company's $5 billion free cash flow stream remains durable.

The Thrive Bridge: $400 Million in Savings the Filing Cannot Guarantee

The Thrive program is the earnings bridge from FY2025's acquisition-distorted trough to margin recovery. Launched in Q3 2025, it targets $500 million in costs over three years and $400 million in annualized savings through "process and automation efficiencies and optimization of our global operating model." The payback math is attractive: a 1.25-year payback period, and if fully realized, the $400 million adds approximately 148 basis points to operating margin.

To understand what Thrive needs to accomplish, look at the cost structure it aims to cut. Compensation and benefits — the dominant expense line — consumed $15.58 billion in FY2025, or 57.7% of total revenue. The R&I segment runs a 56.2% compensation ratio; Consulting runs at 58.3%. Thrive's $400 million savings target represents a 2.6% reduction in the total compensation bill — achievable if automation can displace labor costs in a 95,000-person workforce, but ambitious for a professional services firm where talent is the product.

The filing complicates the bridge thesis in two ways. First, the explicit risk factor language.

"The Program will generate savings from process and automation efficiencies and optimization of our global operating model. However, actual total costs, savings and timing may differ from our estimates due to changes in the scope or assumptions underlying the Program and other operational improvements through BCS. We cannot guarantee that we will achieve the targeted savings."

This is not boilerplate. The filing pairs a $400 million savings target with an explicit acknowledgment that the target may not be met — in the same document. It also notes approximately $250 million in McGriff retention payments over the next two years, meaning the savings program and the integration cost program are running concurrently. Thrive savings may be partially offset by continued integration costs, narrowing the net benefit.

Second, not all segments are positioned to absorb efficiency-driven changes equally. Within Consulting, Mercer's Career segment already declined 2% in FY2025, driven by falling U.S. and Canada project-based work.

"On an underlying basis, revenue for Mercer's Health and Wealth increased 6% and 4%, respectively, and decreased 2% in Career, as compared to the prior year."

Mercer Health (+6%) and Wealth (+4%) provide offsets, and Mercer's $692 billion in managed assets anchors the Wealth segment. But Career's decline signals that parts of the consulting franchise are already under demand pressure — cutting costs in a declining segment risks accelerating the revenue decline rather than improving margins.

The underlying revenue environment adds a further constraint. Of Marsh's 10.3% reported revenue growth, only 4% was organic — the rest was McGriff. The filing explicitly notes the headwind: "underlying revenue growth in 2025 was driven by higher new business and renewal revenue at Marsh Risk and Guy Carpenter, partially offset by declining insurance and reinsurance premium rates." If premium rate softening accelerates, organic growth could fall below 3%, and the Thrive bridge would need to span a longer gap.

Marsh's Thrive program targets $400 million in annual savings against a compensation base of $15.6 billion — requiring a 2.6% reduction in the largest expense line — but the company's own 10-K warns that "we cannot guarantee that we will achieve the targeted savings," and one consulting segment (Career) is already declining 2%.

What to Watch: The Three Numbers That Determine Marsh's Trajectory

At $188 and 5.5% FCF yield, MRSH is priced for a recovery scenario. The market's 21.9x P/E implies approximately 8% annual EPS growth over the next five years — reaching roughly $12.40 by FY2030. For this to materialize, Marsh needs organic growth to hold, Thrive to deliver, and integration costs to normalize, all on a timeline that avoids testing the $19.6 billion debt structure during a downturn.

The filing supports this trajectory. Integration costs should decline from $211 million toward zero by FY2027. Thrive is designed to add 148 basis points over three years. The cash flow engine — 1.27x OCF/NI, 5.5% FCF yield, $291 million capex on $27 billion in revenue — is performing at the highest level among financial services peers.

But the price offers no margin of safety if the assumptions slip. Here are the three numbers that will determine whether the earnings bridge holds:

1. R&I Segment Margin (target: recovery above 27.5-28.0% in FY2026). This is the single most important leading indicator. If R&I margin recovers above 28% in H1 2026, integration is being absorbed and the underlying margin expansion thesis resumes. If it remains below 26.5%, the compression timeline is extending beyond management's framework and the earnings bridge is weakening.

2. Organic Revenue Growth (target: holds at 3.5-4.0%). Only 4% of FY2025 growth was organic. If premium rate softening pushes organic growth below 3% before Thrive savings materialize, the revenue base cannot support the margin recovery math. Watch the Marsh Global Insurance Market Index and management commentary on rate trends in Q1-Q2 2026.

3. OCF/NI Ratio (target: normalizes above 1.10x). The 1.27x in FY2025 may include one-time working capital benefits that partially reverse. If OCF/NI drops below 1.0x, it would mean the exceptional cash conversion was temporary rather than structural — removing the hidden cash quality advantage that underpins the bull case. A sustained ratio above 1.10x confirms the asset-light model's superiority.

The thesis is falsified if all three deteriorate simultaneously: R&I growth below 3%, integration costs above $100 million per half-year, and OCF/NI declining toward 1.0x. Any single condition weakening is manageable. All three converging would mean the earnings bridge is extending beyond the timeline the capital return policy can sustain at 89% of net income.

At $188, investors are paying 18.6x cash earnings for a company with $5 billion in annual free cash flow, the lowest capital intensity in financial services, and a margin recovery program that has not yet produced results. The filing supports the destination — normalized margins, declining integration costs, durable cash generation — but complicates the timeline. The 10:1 cash-to-GAAP divergence is the market's blind spot, and the central question is whether investors are willing to value Marsh on its $5 billion cash flow engine rather than its $8.43 EPS while they wait for the two numbers to converge.

Frequently Asked Questions

Why did Marsh's revenue grow 10% but EPS only grew 3%?

The McGriff acquisition ($7.75B, closed January 2025) drove 6% of the 10% revenue growth, but added $260 million in annual interest expense from acquisition debt. After tax, this interest increase alone cost shareholders approximately $0.40 per share in EPS. Combined with $211M in integration costs and $549M in intangible amortization, acquisition-related charges consumed the earnings contribution from the revenue increase. Only 4% of revenue growth was organic.

Is Marsh's $5 billion free cash flow sustainable?

FY2025 FCF of $5.0 billion benefited from $549M in non-cash intangible amortization, favorable working capital timing, and a deferred tax benefit. The OCF/NI ratio of 1.27x may partially normalize toward 1.10-1.20x. However, the asset-light model (capex just 1.1% of revenue) structurally supports FCF margins above 15%. The most credible base case is $4.5-5.0B annual FCF going forward.

What is the Thrive program and will it deliver the promised savings?

Thrive is a three-year restructuring program launched in Q3 2025, targeting $500M in costs and $400M in annual savings through process automation and operating model optimization. The $400M would add approximately 148 basis points to operating margin. However, the 10-K explicitly warns: "We cannot guarantee that we will achieve the targeted savings." FY2025 already incurred $222M in restructuring charges, and it is unclear how much overlaps with Thrive vs. legacy restructuring.

How much debt does Marsh carry and is it manageable?

Total debt is $19.6 billion ($18.3B long-term + $1.3B current), with net debt of $5.4 billion. Interest coverage is 6.5x, down from 8.3x in FY2024 due to the $260M interest increase from McGriff acquisition debt. Near-term maturities include bonds at 1.349% and 3.750% due in 2026 that will refinance at higher rates. The debt level is manageable given $5B in annual FCF but leaves limited room for error.

Why does Marsh have negative tangible book value of -$29 billion?

Marsh's negative tangible book value (-$29.1B) results from $24.3B in goodwill and $4.7B in intangible assets (from decades of acquisitions) plus $9.3B in treasury stock (from share buybacks) exceeding $27.8B in retained earnings. This is structural for acquisition-driven services firms. The goodwill represents the capitalized value of client relationships, brand, and talent. The filing warns that a goodwill impairment "could have a material adverse effect on our results of operations."

How does Marsh compare to BlackRock and Schwab on cash conversion?

Marsh's OCF/NI ratio of 1.27x is the highest among its peer group. BlackRock converts at 0.71x ($3.9B OCF / $5.6B NI) — significantly lower because BLK's acquisition spree consumed working capital. Schwab converts at approximately 1.11x ($9.3B OCF / $8.4B NI). Citigroup and RY, as banks, use different cash flow frameworks. The comparison highlights Marsh's asset-light advantage: minimal capex, recurring brokerage commissions, and non-cash charges that reduce GAAP income without affecting cash.

Is MRSH stock overvalued at ~$188?

At 21.9x TTM P/E, MRSH trades in line with Schwab (21.5x) and at a discount to BlackRock (22.3x adjusted). Using FCF yield (5.5%), MRSH appears cheaper than BLK (2.1% FCF yield). The valuation assumes ~8% annual EPS growth — achievable if Thrive delivers and organic growth holds at 4%, but aggressive if premium rates soften further. At 18.6x cash earnings ($188 / $10.12 FCF per share), the stock is more reasonably priced on cash metrics.

What are the biggest risks to Marsh's stock?

Three key risks from the filing: (1) Organic growth deceleration — only 4% of FY2025 growth was organic, and the filing notes declining insurance premium rates as a headwind. (2) Thrive execution risk — the filing explicitly cannot guarantee the $400M savings target. (3) Refinancing risk — low-coupon bonds maturing in 2026 will be replaced at higher rates, adding to the interest burden. If organic growth falls below 3% before Thrive savings materialize, the earnings bridge thesis fails.

When will McGriff integration costs stop dragging on earnings?

FY2025 integration costs were $211M, up from $60M in FY2024 (partial year). The filing notes approximately $250M in retention payments over the next 2 years. Integration costs should decline materially by FY2027, with partial normalization in FY2026. The key leading indicator is R&I segment margin — recovery above 28% would signal integration absorption is complete.

Should investors focus on Marsh's EPS or free cash flow?

Given the 10:1 divergence between FCF growth (25.5%) and EPS growth (3.1%), FCF is the more informative metric for FY2025. The $549M in intangible amortization creates a permanent 200 bps GAAP margin drag with zero cash impact. With negative tangible equity making ROE/ROIC meaningless, FCF yield (5.5%) and FCF per share ($10.12) are the most reliable valuation anchors. As integration costs normalize, EPS and FCF should converge.

What does Marsh's segment performance tell investors?

Risk & Insurance (64% of revenue) grew 12.1% but saw margin contract 160 bps to 26.8%, primarily from McGriff integration costs. Consulting (36%) grew 7.2% with flat margins at 19.4%. Within Consulting, Health (+6%) and Wealth (+4%) are growing, but Career declined 2% due to falling U.S./Canada project work. The segment divergence shows R&I is carrying the integration burden while Consulting operates at steady state.

How does Marsh's CEO insider selling affect the investment case?

CEO John Doyle sold 16,655 shares (12.48% of his position) at $183.30, and total insider ownership is only 0.35%. However, the company simultaneously accelerated buybacks from $0.9B to $2.0B and authorized a new $6B program. Insider selling may reflect personal diversification rather than a directional bet. Weight this as a sentiment signal, not a fundamental one.

What is Marsh's Acquisition Quality Bridge and what does it reveal?

The Acquisition Quality Bridge is a two-dimensional framework measuring both the quality of acquired revenue (incremental margin vs. base margin) and the quality of cash generation (OCF/NI ratio). Marsh sits in the "temporarily dilutive" quadrant: low revenue quality (14.1% incremental margin vs. 28.4% base) but high cash quality (1.27x OCF/NI). This combination suggests the GAAP earnings drag is temporary and driven by integration costs, not a permanent structural decline in the business.

Methodology

Data Sources

This analysis is based on Marsh's FY2025 Annual Report (10-K filing), filed February 2026. Filing sections analyzed include: MD&A (Results of Operations, Liquidity and Capital Resources), Risk Factors, and footnotes covering debt, segment performance, accounting policies, stock compensation, and cash and investments. Financial data was extracted through the MetricDuck automated pipeline, which processes SEC XBRL filings for 5,000+ US public companies. Peer comparison data for Citigroup, Charles Schwab, BlackRock, and Royal Bank of Canada was sourced from MetricDuck pipeline extractions of each company's most recent annual filing.

Limitations

• McGriff stand-alone financials are not disclosed. All McGriff-specific analysis relies on incremental segment data — we cannot confirm McGriff's actual stand-alone margin, revenue contribution, or integration synergy realization.
• Thrive vs. legacy restructuring overlap is unclear. FY2025 restructuring of $222M may include both Thrive and legacy restructuring costs. Net incremental savings from Thrive could be smaller than the headline $400M.
• ROIC is not meaningful for MRSH due to near-zero equity. Standard return-on-capital metrics cannot be applied. Cash-based metrics (FCF yield, OCF/NI) are substituted.
• Peer comparison limitations. Citigroup and Royal Bank of Canada are balance-sheet-intensive banks with fundamentally different models from MRSH. Schwab and BlackRock are closer comparables (fee-based, asset-light) but operate in different market segments. The natural peers (AON, WTW, AJG) were not in the assigned peer group.
• Fiduciary cash is not separately quantified. The $14.2B total cash balance includes significant fiduciary cash (client premiums in transit). True operating cash is estimated at $1-2B, affecting the net debt picture and capital return sustainability assessment.
• FY2024 included disposition gains. Revenue in 2024 included gains from the sale of U.K. pension administration and U.S. health/benefits administration businesses, potentially inflating the prior-year base for year-over-year comparisons.
• R&I FY2024 base margin circular derivation. The 28.4% R&I FY2024 base margin was derived from the MetricDuck pipeline (26.8% + 160 bps margin change) rather than independently verified from the FY2024 10-K segment tables. If the pipeline's margin_change_bps figure is incorrect, the current-year margin, prior-year margin, and 14.1% incremental margin spread all fail simultaneously. The incremental margin calculation should be confirmed against the FY2024 10-K R&I segment financials.

Disclaimer:

This analysis is for informational purposes only and does not constitute investment advice. The author does not hold positions in MRSH, C, SCHW, BLK, or RY. Past performance and current metrics do not guarantee future results. All data is derived from public SEC filings and may contain errors or omissions from the automated extraction process.